Literature DB >> 26819516

MicroRNA-mediated interactions between host and hepatitis C virus.

Hu Li1, Jian-Dong Jiang1, Zong-Gen Peng1.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs. More than 2500 mature miRNAs are detected in plants, animals and several types of viruses. Hepatitis C virus (HCV), which is a positive-sense, single-stranded RNA virus, does not encode viral miRNA. However, HCV infection alters the expression of host miRNAs, either in cell culture or in patients with liver disease progression, such as liver fibrosis, cirrhosis, and hepatocellular carcinoma. In turn, host miRNAs regulate HCV life cycle through directly binding to HCV RNAs or indirectly targeting cellular mRNAs. Increasing evidence demonstrates that miRNAs are one of the centered factors in the interaction network between virus and host. The competitive viral and host RNA hypothesis proposes a latent cross-regulation pattern between host mRNAs and HCV RNAs. High loads of HCV RNA sequester and de-repress host miRNAs from their normal host targets and thus disturb host gene expression, indicating a means of adaptation for HCV to establish a persistent infection. Some special miRNAs are closely correlated with liver-specific disease progression and the changed levels of miRNAs are even higher sensitivity and specificity than those of traditional proteins. Therefore, some of them can serve as novel diagnostic/prognostic biomarkers in HCV-infected patients with liver diseases. They are also attractive therapeutic targets for development of new anti-HCV agents.

Entities:  

Keywords:  Biomarker; Hepatitis C virus; Host-virus interaction; MicroRNAs; Therapeutic targets

Mesh:

Substances:

Year:  2016        PMID: 26819516      PMCID: PMC4721982          DOI: 10.3748/wjg.v22.i4.1487

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  80 in total

Review 1.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

2.  Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

Authors:  Rebecca T Marquez; Sarmistha Bandyopadhyay; Erik B Wendlandt; Kathy Keck; Brandon A Hoffer; Michael S Icardi; Randolph N Christensen; Warren N Schmidt; Anton P McCaffrey
Journal:  Lab Invest       Date:  2010-07-12       Impact factor: 5.662

3.  Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.

Authors:  Hisashi Ishida; Tomohide Tatsumi; Atsushi Hosui; Takatoshi Nawa; Takahiro Kodama; Satoshi Shimizu; Hayato Hikita; Naoki Hiramatsu; Tatsuya Kanto; Norio Hayashi; Tetsuo Takehara
Journal:  Biochem Biophys Res Commun       Date:  2011-07-23       Impact factor: 3.575

4.  Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.

Authors:  Joydip Bhanja Chowdhury; Shubham Shrivastava; Robert Steele; Adrian M Di Bisceglie; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

5.  MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2).

Authors:  Seonhoe Kim; Ui Jin Lee; Mi Na Kim; Eun-Ju Lee; Ji Young Kim; Mi Young Lee; Sorim Choung; Young Joo Kim; Young-Chul Choi
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

6.  Interferon modulation of cellular microRNAs as an antiviral mechanism.

Authors:  Irene M Pedersen; Guofeng Cheng; Stefan Wieland; Stefano Volinia; Carlo M Croce; Francis V Chisari; Michael David
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

7.  Selective degradation of host MicroRNAs by an intergenic HCMV noncoding RNA accelerates virus production.

Authors:  Sanghyun Lee; Jaewon Song; Sungchul Kim; Jongkyu Kim; Yujin Hong; Youngkyun Kim; Donghyun Kim; Daehyun Baek; Kwangseog Ahn
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

8.  Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo.

Authors:  Lisa Marcinowski; Mélanie Tanguy; Astrid Krmpotic; Bernd Rädle; Vanda J Lisnić; Lee Tuddenham; Béatrice Chane-Woon-Ming; Zsolt Ruzsics; Florian Erhard; Corinna Benkartek; Marina Babic; Ralf Zimmer; Joanne Trgovcich; Ulrich H Koszinowski; Stipan Jonjic; Sébastien Pfeffer; Lars Dölken
Journal:  PLoS Pathog       Date:  2012-02-09       Impact factor: 6.823

9.  Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection.

Authors:  Shashi Bala; Yaphet Tilahun; Odette Taha; Hawau Alao; Karen Kodys; Donna Catalano; Gyongyi Szabo
Journal:  J Transl Med       Date:  2012-07-30       Impact factor: 5.531

10.  Replication priority of hepatitis C virus genotype 2a in a Chinese cohort.

Authors:  Zhen Yang; Yongxin Yu; Hongzhong Zhang; Guifang Shang; Jialiang Gao; Jian-Dong Jiang; Zonggen Peng
Journal:  Acta Pharm Sin B       Date:  2014-07-14       Impact factor: 11.413

View more
  21 in total

1.  Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde.

Authors:  Murali Ganesan; Sathish Kumar Natarajan; Jinjin Zhang; Justin L Mott; Larisa I Poluektova; Benita L McVicker; Kusum K Kharbanda; Dean J Tuma; Natalia A Osna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-07       Impact factor: 4.052

2.  Exosomal MicroRNAs Derived From Umbilical Mesenchymal Stem Cells Inhibit Hepatitis C Virus Infection.

Authors:  Xijing Qian; Chen Xu; Shuo Fang; Ping Zhao; Yue Wang; Houqi Liu; Wen Yuan; Zhongtian Qi
Journal:  Stem Cells Transl Med       Date:  2016-08-05       Impact factor: 6.940

3.  MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination-what we learned from microRNA-494.

Authors:  Margarita González-Vallinas; Kai Breuhahn
Journal:  Hepatobiliary Surg Nutr       Date:  2016-08       Impact factor: 7.293

Review 4.  Role of circulatory microRNAs in the pathogenesis of hepatitis C virus.

Authors:  Iqra Almas; Samia Afzal; Muhammad Idrees; Muhammad Usman Ashraf; Iram Amin; Muhammad Shahid; Khadija Zahid; Sadia Zahid
Journal:  Virusdisease       Date:  2017-11-27

5.  A novel microRNA boosts hyper-β-oxidation of fatty acids in liver by impeding CEP350-mediated sequestration of PPARα and thus restricts chronic hepatitis C.

Authors:  Suchandrima Ghosh; Joyeeta Chakraborty; Avijit Goswami; Sayantani Bhowmik; Susree Roy; Amit Ghosh; Sakshi Dokania; Priyanka Kumari; Simanti Datta; Abhijit Chowdhury; Suvendra Nath Bhattacharyya; Raghunath Chatterjee; Soma Banerjee
Journal:  RNA Biol       Date:  2020-06-07       Impact factor: 4.652

6.  Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Nearmeen M Rashad; Amal S El-Shal; Sally M Shalaby; Salem Y Mohamed
Journal:  Mol Cell Biochem       Date:  2018-02-17       Impact factor: 3.396

7.  Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.

Authors:  Katharina Herzog; Simonetta Bandiera; Sophie Pernot; Catherine Fauvelle; Frank Jühling; Amélie Weiss; Anne Bull; Sarah C Durand; Béatrice Chane-Woon-Ming; Sébastien Pfeffer; Marion Mercey; Hervé Lerat; Jean-Christophe Meunier; Wolfgang Raffelsberger; Laurent Brino; Thomas F Baumert; Mirjam B Zeisel
Journal:  Gut       Date:  2019-05-10       Impact factor: 31.793

8.  Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.

Authors:  Bao-Min Shi; Wen Lu; Kun Ji; Yu-Feng Wang; Shuai Xiao; Xiu-Yan Wang
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

9.  Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection.

Authors:  Yung-Ju Yeh; Ching-Ping Tseng; Sheng-Da Hsu; His-Yuan Huang; Michael M C Lai; Hsien-Da Huang; Ju-Chien Cheng
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

10.  MicroRNA-203-3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2.

Authors:  Xi-Feng Fu; Hai-Chao Zhao; Chuan-Li Yang; Chang-Zhou Chen; Kang Wang; Fei Gao; Yang-Zhang Tian; Hao-Liang Zhao
Journal:  Oncol Lett       Date:  2021-06-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.